SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 276 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $17,204,000 | -67.2% | 626,040 | -60.5% | 0.14% | -67.8% |
Q2 2019 | $52,485,000 | -4.0% | 1,586,125 | +1.6% | 0.44% | -7.5% |
Q1 2019 | $54,680,000 | +5.2% | 1,560,515 | -0.3% | 0.48% | -9.7% |
Q4 2018 | $51,995,000 | -22.4% | 1,565,185 | +17.6% | 0.53% | -11.1% |
Q3 2018 | $67,001,000 | -11.7% | 1,330,705 | +4.9% | 0.59% | -19.2% |
Q2 2018 | $75,905,000 | +30.0% | 1,268,255 | -0.5% | 0.74% | +16.5% |
Q1 2018 | $58,402,000 | +20.8% | 1,275,155 | +5.1% | 0.63% | +15.4% |
Q4 2017 | $48,329,000 | -1.8% | 1,212,785 | -1.4% | 0.55% | -5.9% |
Q3 2017 | $49,199,000 | +53.0% | 1,229,975 | +64.9% | 0.58% | +47.8% |
Q2 2017 | $32,149,000 | – | 745,917 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |